Status:
COMPLETED
Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases
Lead Sponsor:
Mayo Clinic
Conditions:
Liver Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction of RT and immunotherapy. Research imaging will be in addition to standard imaging studies performed at time ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of solid cancers with the presence of one or more liver metastases
- Minimum metastasis diameter ≥ 2 cm
- Planning to receive radiation therapy with immunotherapy
- Willingness to participate in mandatory imaging studies at Mayo Clinic Rochester
Exclusion
- Contraindications for MRI including claustrophobia, pace maker, metal implants, aneurism clips
- Patients who are not able to consent
Key Trial Info
Start Date :
August 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03401814
Start Date
August 2 2018
End Date
December 12 2019
Last Update
July 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905